Inventor
ERIK JAMES HICKEN
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes25%
C07CAcyclic or carbocyclic compounds10%
H05KPrinted circuits5%
PatentTitleYear
12,447,153HER2 mutation inhibitors202511,932,633KRas G12C inhibitors202411,834,453Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors202311,634,409Compounds for the treatment of BRAF-associated diseases and disorders202311,414,404Compounds for the treatment of BRAF-associated diseases and disorders202211,267,812KRAS G12C inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to ARRAY BIOPHARMA INC (6)· patent assignee history
2022–2024Patents assigned to MIRATI THERAPEUTICS INC (2)· patent assignee history
2022–2025Based in US· patent location history
2025Patents assigned to PFIZER (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ARRAY BIOPHARMA INC | 6 | 2022–2025 |
| MIRATI THERAPEUTICS INC | 2 | 2022–2024 |
| PFIZER | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2025 |